Enovix (NASDAQ:ENVX) Stock Price Down 6.5% - What's Next?

Key Points

• Enovix shares fell 6.5% to about $3.25 on below-average trading volume, remaining below both its 50-day and 200-day moving averages.
• Analyst sentiment remains mixed but leans positive: the stock has a “Moderate Buy” consensus rating and an $11.77 average price target, despite several recent target cuts and one sell rating.
• The company beat quarterly estimates with adjusted EPS of -$0.13 versus -$0.15 expected and revenue of $9.02 million, up 20.8% year over year; however, it continues to report substantial net losses and negative profitability metrics.

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s share price fell 6.5% on Wednesday . The company traded as low as $3.25 and last traded at $3.2450. 2,775,532 shares were traded during trading, a decline of 58% from the average session volume of 6,632,543 shares. The stock had previously closed at $3.47.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ENVX. B. Riley Financial decreased their price target on Enovix from $10.00 to $9.00 and set a "buy" rating for the company in a report on Thursday, August 13th. Benchmark reduced their target price on shares of Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research note on Thursday, May 14th. Bank of America reaffirmed a "neutral" rating and issued a $5.00 target price on shares of Enovix in a report on Monday, August 17th. Oppenheimer cut their price target on shares of Enovix from $24.00 to $21.00 and set an "outperform" rating for the company in a report on Thursday, May 14th. Finally, Weiss Ratings restated a "sell (e+)" rating on shares of Enovix in a research report on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $11.77.

Enovix Price Performance

The stock has a market cap of $705.53 million, a price-to-earnings ratio of -3.97 and a beta of 2.31. The company's 50 day moving average is $4.24 and its 200 day moving average is $5.50. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37.

Enovix (NASDAQ:ENVX - Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The company had revenue of $9.02 million during the quarter, compared to analysts' expectations of $8.43 million. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The firm's quarterly revenue was up 20.8% compared to the same quarter last year. During the same period last year, the company posted ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. Research analysts forecast that Enovix Corporation will post -0.8 earnings per share for the current fiscal year.

Institutional Trading of Enovix

Several large investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Enovix by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company's stock worth $129,831,000 after buying an additional 1,747,145 shares during the last quarter. BlackRock Inc. acquired a new position in Enovix during the second quarter worth about $100,054,000. Electron Capital Partners LLC grew its position in shares of Enovix by 13.8% in the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company's stock valued at $80,143,000 after purchasing an additional 972,103 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Enovix by 6.1% during the 4th quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company's stock worth $32,268,000 after purchasing an additional 253,906 shares in the last quarter. Finally, State Street Corp lifted its stake in Enovix by 2.0% in the 4th quarter. State Street Corp now owns 3,959,029 shares of the company's stock valued at $28,941,000 after buying an additional 77,079 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company's stock.

Enovix Company Profile

Enovix Corporation NASDAQ: ENVX develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.